跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Indrex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Indrex
Approved
STANDARD
Indrex
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7560d574fb58c754
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
7560d574fb58c754
Drug Approval Philippines Name
Indrex
Product Name
Indrex
Registration Number
DR-XY47697
Brand Name
Indrex
Generic Name
Propranolol Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
Medchoice Distribution, Inc.
Issuance Date
28 January 2022
Expiry Date
28 January 2027
Pharmacologic Category
Non-selective Beta Blocking Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7560d574fb58c754
Type
Standard
Back to Philippines FDA Approvals